ESPOSITO, Carla
 Distribuzione geografica
Continente #
NA - Nord America 6.610
AS - Asia 4.431
EU - Europa 2.052
SA - Sud America 304
AF - Africa 33
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.436
Nazione #
US - Stati Uniti d'America 6.511
HK - Hong Kong 2.163
SG - Singapore 977
CN - Cina 740
IT - Italia 512
UA - Ucraina 495
VN - Vietnam 278
DE - Germania 263
BR - Brasile 260
RU - Federazione Russa 224
FI - Finlandia 156
IE - Irlanda 139
TR - Turchia 82
SE - Svezia 76
GB - Regno Unito 52
FR - Francia 48
MX - Messico 48
KR - Corea 45
CA - Canada 40
IN - India 40
JP - Giappone 20
AR - Argentina 19
PL - Polonia 19
BD - Bangladesh 17
ZA - Sudafrica 15
ES - Italia 14
IQ - Iraq 14
CZ - Repubblica Ceca 13
PK - Pakistan 8
IL - Israele 7
AT - Austria 6
CL - Cile 6
MA - Marocco 6
ID - Indonesia 5
JO - Giordania 5
LT - Lituania 5
PH - Filippine 5
RS - Serbia 5
VE - Venezuela 5
CO - Colombia 4
EC - Ecuador 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
NL - Olanda 3
RO - Romania 3
AO - Angola 2
AU - Australia 2
BG - Bulgaria 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KE - Kenya 2
MN - Mongolia 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
RW - Ruanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
TV - Tuvalu 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 13.435
Città #
Hong Kong 2.161
Ann Arbor 1.338
Wilmington 691
Chandler 619
Jacksonville 596
Dallas 511
Singapore 473
Princeton 393
Ashburn 282
Houston 265
Dong Ket 210
Woodbridge 209
San Jose 167
Beijing 145
Munich 139
Dublin 136
Boardman 111
Nanjing 110
Dearborn 107
Andover 97
Pellezzano 76
Salerno 65
Izmir 62
Los Angeles 49
Mestre 49
Moscow 49
Fairfield 41
Helsinki 41
Redwood City 37
Nanchang 35
The Dalles 35
Hebei 33
Shenyang 33
New York 30
São Paulo 30
Ho Chi Minh City 28
Changsha 27
Tianjin 21
Jiaxing 20
Tokyo 20
Pune 19
Warsaw 19
Montreal 18
Napoli 16
Sant'agata De' Goti 16
Washington 15
Brooklyn 14
Cuauhtémoc 14
Orem 14
Santa Clara 14
Agropoli 13
Brno 12
London 12
Norwalk 12
Phoenix 12
Stockholm 12
Turku 12
Belo Horizonte 11
Cava 11
Düsseldorf 11
Johannesburg 11
Ottawa 11
San Diego 11
Seattle 11
Guangzhou 10
Chennai 9
Chicago 9
Istanbul 9
Lessolo 9
Poplar 9
Boston 8
Hanoi 8
Manchester 8
Naples 8
Potenza 8
Rio de Janeiro 8
Spinea 8
Atlanta 7
Bari 7
Bologna 7
Caserta 7
Council Bluffs 7
Jinan 7
Ankara 6
Denver 6
Kunming 6
Marsico Nuovo 6
Mexico City 6
Shanghai 6
Amman 5
Belgrade 5
Charlotte 5
Curitiba 5
Haiphong 5
Hefei 5
Portici 5
Querétaro 5
San Francisco 5
Springfield 5
Vienna 5
Totale 10.106
Nome #
Searching for the protein targets of 4-nonylphenol using a computational approach 703
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells 632
A preliminary study on nonylphenol toxicity in human intestinal epithelial cells 553
The surfactant 4-nonylphenol is cytotoxic for cells of the human gastrointestinal tract. 319
Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. 267
Searching for the protein targets of 4-nonylphenol using a computational approach 249
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. 230
Analysis of transglutaminase protein substrates by functional proteomics. 212
4-Nonylphenol reduces cell viability and induces apoptosis and ER-stress in a human epithelial intestinal cell line 183
An acetic acid-based extraction method to obtain high quality collagen from archeological bone remains 176
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 174
Celiac anti‑type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects 173
Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease 170
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 169
Antibodies against type 2 transglutaminase modulate actin rearrangements and cell cycle in several cell lines 159
Application of a computational approach to identify protein targets for 4-nonylphenol 156
The toxic alpha-gliadin peptide 31-43 enters cells without a surface membrane receptor 154
Celiac autoantibodies to tissue transglutaminase modulate alpha-gliadin peptide uptake by epithelial cells 147
THE A-GLIADIN PEPTIDE 31-43 INDUCES NF-kB ACTIVATION AND MODULATE TYPE 2 TRANSGLUTAMINASE ACTIVITY IN AN INTESTINAL EPITHELIAL CELL LINE 143
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics 143
Interaction of 'toxic' and 'immunogenic' A-gliadin peptides with a membrane-mimetic environment 142
Enzymatic Strategies to Detoxify Gluten:Implications for Celiac Disease 142
Autoantibodies to tissue transglutaminase can induce ER (endoplasmic reticulum) stress response in Caco-2 cells 140
Chronic Exposure to Cadmium Disrupts the Adrenal Gland Activity of the Newt Triturus carnifex (Amphibia, Urodela) 140
Anti-Tissue Transglutaminase Antibodies from Coeliac Patients Inhibit Transglutaminase Activity both in Vitro and in Situ 138
ANTI-TISSUE TRANSGLUTAMINASE ANTIBODIES ACTIVATE CYTOSOLIC TISSUE TRANSGLUTAMINASE BY MOBILIZING CALCIUM IONS FROM INTRACELLULAR STORES 138
Gliadin Peptides Induce Tissue Transglutaminase Activation and ER-Stress through Ca(2+) Mobilization in Caco-2 Cells. 137
A-gliadin peptide 31-43 induces NF-κB and tissue transglutaminase activation in an intestinal epithelial cell line 137
Identification of differential phosphorylated proteins in Caco-2 cells treated with anti-tissue transglutaminase antibodies 137
Synthesis of peptidocalix[4]arene diversomers as transglutaminase inhibitors by protein surface recognition 136
Tissue transglutaminase in celiac disease: role of autoantibodies. 134
Biochemical characterization of recombinant rat prostate transglutaminase expressed into MDCK cells 129
Anti-tissue transglutaminase antibodies have biological effects on cultured intestinal biopsies from celiac patients 126
Caratterizzazione della transglutaminasi da prostata di ratto espressa in cellule MDCK 123
A-GLIADIN PEPTIDES INDUCE TISSUE TRANSGLUTAMINASE ACTIVATION THROUGH CA2+ MOBILIZATION IN CACO-2 CELLS 122
Serum IgA and IgG and intestinal monoclonal anti-tissue transglutaminase antibodies from coeliac patients inhibit the catalytic activity both in vitro and in situ. 121
Subcellular distribution of type 2 transglutaminase is constitutively different in skin derived-fibroblasts from celiac disease patients and from healthy controls 118
New therapeutic strategies for coeliac disease: tissue transglutaminase as a target 117
Mammalian Transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. 116
Internalization of alpha gliadin peptide 31-43 by Caco-2 cells does not require a surface receptor. 116
Histological changes, apoptosis and metallothionein levels in Triturus carnifex (Amphibia, Urodela) exposed to environmental cadmium concentrations 114
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 113
Constitutive differential features of type 2 transglutaminase in cells derived from celiac patients and from healthy subjects 113
N-terminus end of rat prostate transglutaminase is responsible for its catalytic activity and GTP binding 113
Expression and enzymatic activity of small intestinal tissue transglutaminase in coeliac disease 112
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types 109
Type 2 transglutaminase contributes to define a cellular phenotype typical of celiac cells. 109
Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line: implications for coeliac disease. 107
Celiac anti-tissue transglutaminase autoantibodies interfere with the ability of alpha-gliadin peptide 31-43 to drive intestinal epithelial cells into S-phase. 106
Celiac anti-tissue transglutaminase antibodies derange alpha gliadin peptide 31-43 uptake by epithelial cells. 105
Transglutaminase 2 in celiac diasease: Minireview article 104
Seminal Vesicle Protein IV and Its Derived Active Peptides: A Possible Physiological Role in Seminal Clotting. 101
GTPase and transglutaminase are associated in the secretion of rat anterior prostate. 100
Tissue Transglutaminase and Coeliac Disease. 100
Transglutaminase surface recognition by peptidocalix[4]arene diversomers. 100
Studi di specificità di isoforme dell'enzima transglutaminasi per modificare proteine del latte 100
The monoclonal anti-tissue transglutaminase antibody CUB 7402 reduces the alpha-gliadin peptides uptake by Caco-2 cells 99
Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate deydrogenase and polyglutamine repeat. 99
null 98
Expression and Enzymatic Activity of Small Intestinal Tissue Transglutaminase in Coeliac Disease 98
Tissue transglutaminase is implicated in the antiproliferative and proapoptotic effect induced by the histone deacetylase inhibitor 97
Tissue transglutaminase modulators regulate actin rearrangements and cell cycle in several cell types 96
Non celiac patients’ anti-tissue transglutaminase antibodies: immunological and functional characterization. 95
The Pituitary-adrenal gland Activity of Triturus carnifex (Amphibia, Urodela) exposed to Environmental Cadmium Concentrations 93
Interplay between type 2 transglutaminase (Tg2), gliadin peptide 31-43 and anti-tg2 antibodies in celiac disease 93
Identification of acyl-acceptor and acyl-donor substrates for transglutaminase in CaCo-2 intestinal cell line: implications for coeliac disease 91
Serum immunoglobulin A and G and monoclonal antibodies anti tissue-transglutaminase from coeliac patients inhibit the catalytic activity both in vitro and in situ. 91
Studio del riconoscimento tra transglutaminasi di tipo 2 e auto-anticorpi anti-transglutaminasi caratteristici della malattia celiaca 89
Effects of Methyl Bromide on activity of blood coagulation enzymes 89
Riconoscimento di superficie delle transglutamminasi mediante diversomeri peptidocalix[4]arenici 88
Influenza delle modifiche post-traduzionali sulle proprietà biologiche della TGasi presente nel secreto della ghiandola coagulatoria 88
Implication of cell-surface transglutaminase in gliadin peptides uptake by Caco-2 cells 87
Transglutaminase-mediated amine incorporation into substance P protects the peptide against proteolysis in vitro. 85
Interaction of “toxic” and “immunogenic” A-gliadin peptides with a membrane-like environment in vitro. 85
Transglutaminase surface recognition by peptidocalix[4]arene diversomers 85
Characterisation of rat coagulating gland transglutaminase expressed in heterologous cell systems 82
Transglutaminase-synthesized spermine derivative of substance P recognizes rat portal vein neurokinin-3 receptors. 81
Role of type 2 transglutaminase autoantibodies in phatogenesis of celiac disease 80
Transglutaminase-synthesized analogs of substance P is a selective tool for neurokinin-2 receptors. 79
Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats. 79
Rat coagulating gland secretion contains a kinesin heavy chain-like protein acting as type IV transglutaminase substrate 79
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types. 79
Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells 78
Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates the VIP/PACAP receptor activity. 78
Studies on transglutaminase type IV in relation to proteins occuring in rat coagulating gland secretion 78
Do tissue transglutaminase antibodies contribute to the intestinal lesion in celiac disease? 78
Identification of tissue transglutaminase-reactive lysine residues in glyceraldheide-3-phosphate dehydrogenase 76
Espressione e attività enzimatica della transglutaminasi tissutale nella mucosa intestinale di pazienti celiaci 76
Overlapping between fluorescence modifications and activation of prostate transglutaminase induced by sodium dodecylsulphate. 75
The mechanism of cytotoxicity of 4-nonylphenol in a human hepatic cell line involves ER-stress, apoptosis, and mitochondrial dysfunction 75
Implication of tissue transglutaminase and desmoplakin in cell adhesion mechanism in human epidermis 73
Enzymatic synthesis of vasoactive intestinal peptide analogs by transglutaminase. 73
null 71
Protein SV-IV promotes nitric oxide production not associated with apoptosis in murine macrophages. 71
Desmoplakin acts as transglutaminase substrate in vitro. 71
Expression and enzymatic activity of transglutaminase in the normal and coeliac small intestinal mucosa 71
Structural characterisation of transglutaminase-catalysed protein aggregates correlated to neurodegenerative disorders. 70
IgA e IgG sieriche e anticorpi monoclonali intestinali anti-transglutaminasi tissutale ottenuti da pazienti celiaci inibiscono l'attività catalitica sia in vitro che in situ 69
null 67
Coeliac disease and extraintestinal autoimmunity. 66
Totale 13.048
Categoria #
all - tutte 41.609
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.609


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021603 0 0 0 0 0 0 112 9 132 13 115 222
2021/2022769 0 0 4 2 40 13 1 25 114 87 121 362
2022/20231.343 134 103 31 176 186 260 0 166 196 0 64 27
2023/2024465 48 68 33 21 38 81 23 31 0 26 19 77
2024/20251.308 62 27 54 88 58 147 268 146 183 33 112 130
2025/20264.456 540 980 1.501 330 592 272 241 0 0 0 0 0
Totale 13.648